GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes

Documenti analoghi

• Lipid Profile Differences in HIV‐Infected Populations With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis
  di: Yovita Hartantri, et al.
  Pubblicazione: (2025)
• Cardiovascular disease mortality and air pollution in countries with different socioeconomic status
  di: Nikolai Khaltaev, et al.
  Pubblicazione: (2024)
• Taking Into Account Insulin Resistance With Associated Hyperinsulinemia to Counteract the Development of Acute and Chronic Cardiovascular Diseases
  di: Serafino Fazio, et al.
  Pubblicazione: (2026)
• Cardiovascular Risk Assessment and Its Determinants Among Older Adults in India: Evidence From a Nationally Representative Survey
  di: Vansh Maheshwari, et al.
  Pubblicazione: (2026)
• Burden of Liver Disease Among Individuals With Turner Syndrome and Klinefelter Syndrome: A Comprehensive Perspective
  di: Mohamad Jamalinia, et al.
  Pubblicazione: (2026)